Application Procedure and Selection Process

Individuals with M.D., M.D./Ph.D., or D.O. training who are interested in an academic career in pediatric hematology-oncology are encouraged to apply. The applicant must be in or have completed an ACGME-accredited general pediatrics or combined medicine/pediatrics residency and have passed the USMLE steps 1 and 2.

Due to the rigorous clinical demands of our fellowship program, ACGME-accredited residency training is a prerequisite for acceptance, as this ensures proficiency in performing within the United States medical system.

In order for our trainees to be board-eligible in pediatric hematology/oncology at the end of their fellowship training, they must first be board-certified in general pediatrics through the American Academy of Pediatrics. UCSD does accept applicants with J1 visas, but not those with H1B visas.

The UCSD Pediatric Hematology Oncology Fellowship program accepts two fellows each year. The program accepts applications for the 3-year ACGME-accredited Pediatric Hematology-Oncology fellowship program through ERAS

For the 2023-2024 fellowship interview season, our program will not be participating in the fellowship match through ERAS as we have filled our 2024 fellowship spots with internal candidates through our UCSD Pediatric Residency Research Track. We will be accepting fellowship applicants through ERAS in future years.​

For questions regarding eligibility and application process please contact:
 

Adriana Aguilar | Fellowship Coordinator
Division of Hematology/Oncology 
Rady Children's Hospital-San Diego 
3020 Children's Way, MC 5035 
San Diego, CA 92123-4282 
Phone: (858) 576-1700, ext. 5648 | Fax: (858) 966-8035
aaguilar5@rchsd.org 


Lynne Robert | Supervisor, Unit Business Support
Division of Hematology/Oncology 
Rady Children's Specialists of San Diego - A Medical Foundation
3020 Children's Way, MC 5035
San Diego, CA 92123
Phone: (858) 966-1700, ext. 225648 | Fax: (858) 966-8035
lrobert@rchsd.org 

If you are interested in applying to our program, please review the following documentation:

Terms and Conditions